Aimee O. Hersh
No Rating Available
(Learn About Our Rating System)

Aimee O. Hersh, MD

Languages spoken: English, Spanish

Clinical Locations

Eccles Primary Children's Outpatient Services

Salt Lake City
801-213-3599

Layton Parkway Clinic

Primary Children's Hospital Outpatient Services at Layton Hospital, Pediatric Rheumatology
Layton
801-213-3599

  • Dr. Aimee Hersh received her medical degree from Brown Medical School and completed her residency and clinical fellowship in Pediatric Rheumatology at University of California, San Francisco. She is currently an Associate Professor in Pediatric Rheumatology and Division Chief of Pediatric Rheumatology at the University of Utah School of Medicine and Primary Children’s Hospital. She is an elected member of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Steering Committee and Chair of the Lupus Committee. Her research focuses on understanding the long-term medical and psychosocial outcomes of patients with childhood-onset systemic lupus erythematosus and juvenile idiopathic arthritis.

    Specialties

    Board Certification

    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Peds Rheumatology)

  • Dr. Aimee Hersh received her medical degree from Brown Medical School and completed her residency and clinical fellowship in Pediatric Rheumatology at University of California, San Francisco. She is currently an Associate Professor in Pediatric Rheumatology and Division Chief of Pediatric Rheumatology at the University of Utah School of Medicine and Primary Children’s Hospital. She is an elected member of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Steering Committee and Chair of the Lupus Committee. Her research focuses on understanding the long-term medical and psychosocial outcomes of patients with childhood-onset systemic lupus erythematosus and juvenile idiopathic arthritis.

    Board Certification and Academic Information

    Academic Departments Pediatrics -Primary
    Board Certification
    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Peds Rheumatology)

    Education history

    Fellowship Rheumatology - University of California, San Francisco Fellow
    Residency Pediatrics - University of California, San Francisco Resident
    Graduate Training Clinical Epidemiology - Dartmouth College M.S.
    Professional Medical Medicine - Brown Medical School M.D.
    Undergraduate Spanish - Whitman College B.A.

    Selected Publications

    Journal Article

    1. Kohli AT, Hersh AO, Ponder L, Chan LHK, Rouster-Stevens KA, Tebo AE, Kugathasan S, Guthery SL, Bohnsack JF, Prahalad S (2023). Prevalence of tissue transglutaminase antibodies and IgA deficiency are not increased in juvenile idiopathic arthritis: a case-control study. Pediatr Rheumatol Online J, 21(1), 110. (Read full article)
    2. Huang Y, Sompii-Montgomery L, Patti J, Pickering A, Yasin S, Do T, Baker E, Gao D, Abdul-Aziz R, Behrens EM, Canna S, Clark M, Co DO, Collins KP, Eberhard B, Friedman M, Graham TB, Hahn T, Hersh AO, Hobday P, Holland MJ, Huggins J, Lu PY, Mannion ML, Manos CK, Neely J, Onel K, Orandi AB, Ramirez A, Reinhardt A, Riskalla M, Santiago L, Stoll ML, Ting T, Grom AA, Towe C, Schulert GS (2023). Disease Course, Treatments, and Outcomes of Children With Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease. Arthritis Care Res (Hoboken). (Read full article)
    3. Smitherman EA, Chahine RA, Beukelman T, Lewandowski LB, Rahman AKMF, Wenderfer SE, Curtis JR, Hersh AO, CARRA Registry Investigators (2023). Childhood-Onset Lupus Nephritis in the Childhood Arthritis and Rheumatology Research Alliance Registry: Short-Term Kidney Status and Variation in Care. Arthritis Care Res (Hoboken), 75(7), 1553-1562. (Read full article)
    4. Melega S, Brogan P, Cleary G, Hersh AO, Kasapcopur O, Rangaraj S, Yeung RSM, Zeft A, Cooper J, Pordeli P, Kirchner P, Lehane PB (2022). Evaluation of Serious Infection in Pediatric Patients with Low Immunoglobulin Levels Receiving Rituximab for Granulomatosis with Polyangiitis or Microscopic Polyangiitis. Rheumatol Ther, 9(2), 721-734. (Read full article)
    5. Cannon L, Wenderfer SE, Lewandowski LB, Cooper JC, Goilav B, Knight AM, Hersh AO, Ardoin SP, Sadun RE, CARRA Lupus Nephritis Workgroup (2022). Use of EuroLupus Cyclophosphamide Dosing for the Treatment of Lupus Nephritis in Childhood-onset Systemic Lupus Erythematosus in North America. J Rheumatol, 49, 607-614. (Read full article)
    6. Johnson KR, Edens C, Sadun RE, Chira P, Hersh AO, Goh YI, Hui-Yuen J, Singer NG, Spiegel LR, Stinson JN, White PH, Lawson E, CARRA Transition Workgroup (2021). Differences in Healthcare Transition Views, Practices, and Barriers Among North American Pediatric Rheumatology Clinicians From 2010 to 2018. J Rheumatol, 48(9), 1442-1449.
    7. Vazzana KM, Daga A, Goilav B, Ogbu EA, Okamura DM, Park C, Sadun RE, Smitherman EA, Stotter BR, Dasgupta A, Knight AM, Hersh AO, Wenderfer SE, Lewandowski LB, CARRA Registry investigators (2021). Principles of pediatric lupus nephritis in a prospective contemporary multi-center cohort. Lupus, 30(10), 1660-1670. (Read full article)
    8. Feldman CH, Speyer C, Ashby R, L Bermas B, Bhattacharyya S, Chakravarty E, Everett B, Ferucci E, Hersh AO, Marty FM, Merola JF, Ramsey-Goldman R, Rovin BH, Son MB, Tarter L, Waikar S, Yazdany J, Weissman JS, Costenbader KH (2019). Development of a Set of Lupus-Specific, Ambulatory Care-Sensitive, Potentially Preventable Adverse Conditions: A Delphi Consensus Study. Arthritis Care Res (Hoboken), 73(1), 146-157. (Read full article)
    9. Haro SL, Lawson EF, Hersh AO (2020). Disease activity and health-care utilization among young adults with childhood-onset lupus transitioning to adult care: data from the Pediatric Lupus Outcomes Study. Lupus, 29(10), 1206-1215. (Read full article)
    10. Ardoin SP, Daly RP, Merzoug L, Tse K, Ardalan K, Arkin L, Knight A, Rubinstein T, Ruth N, Wenderfer SE, Hersh AO, Childhood Arthritis and Rheumatology Research Alliance and Lupus Foundation of America (2019). Research priorities in childhood-onset lupus: results of a multidisciplinary prioritization exercise. Pediatr Rheumatol Online J, 17(1), 32. (Read full article)
    11. Ravindra VM, Mazur MD, Mohila CA, Sweney MT, Hersh A, Bollo RJ (2015). Rasmussen encephalitis with dual pathology in a patient without seizures: case report and literature review. Childs Nerv Syst, 31(11), 2165-71. (Read full article)
    12. Bennett TD, Fluchel M, Hersh AO, Hayward KN, Hersh AL, Brogan TV, Srivastava R, Stone BL, Korgenski EK, Mundorff MB, Casper TC, Bratton SL (2012). Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis. Arthritis Rheum, 64(12), 4135-42. (Read full article)
    13. Mina R, von Scheven E, Ardoin SP, Eberhard BA, Punaro M, Ilowite N, Hsu J, Klein-Gitelman M, Moorthy LN, Muscal E, Radhakrishna SM, Wagner-Weiner L, Adams M, Blier P, Buckley L, Chalom E, Chedeville G, Eichenfield A, Fish N, Henrickson M, Hersh AO, Hollister R, Jones O, Jung L, Levy D, Lopez-Benitez J, McCurdy D, Miettunen PM, Quintero-del Rio AI, Rothman D, Rullo O, Ruth N, Schanberg LE, Silverman E, Singer NG, Soep J, Syed R, Vogler LB, Yalcindag A, Yildirim-Toruner C, Wallace CA, Brunner HI (2012). Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus. Arthritis Care Res (Hoboken), 64(3), 375-83. (Read full article)
    14. Hersh AO, von Scheven E, Yazdany J, Panopalis P, Trupin L, Julian L, Katz P, Criswell LA, Yelin E (2009). Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus. Arthritis Rheum, 61(1), 13-20. (Read full article)

  • News & Podcasts

    News

  • Clinical Trials